Firm fixed price award
Ended Awarded Last action
- Contract number
- 75F40122F80341
- Awardee
-
Next Phase Solutions And Services, Inc. UEI GF3NMJ8FFSC1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $4,499,216
Award facts
- Contract value 100% obligated
- $4,499,216.42 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $3,076,947 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,422,270 |
About this award
The Food and Drug Administration issued a delivery order to Next Phase Solutions And Services, Inc., an economically disadvantaged woman-owned small business and SBA 8(a) Program Participant, on August 30, 2022, under the 8(a) STARS III GWAC with a ceiling value of $4,499,216.42 for Center for Drug Evaluation and Research integrated enterprise information management assessment support.
The order is firm fixed price with place of performance in Silver Spring, Maryland. Ultimate completion is scheduled for September 26, 2024. SCI reporting shows FY2023 invoicing of $1.4 million across 2.5 FTEs and 5,282 contractor hours ($269.28/hr blended rate), and FY2024 invoicing of $3.1 million across 3.1 FTEs and 6,524 contractor hours ($471.64/hr). FY2024 teaming included one subcontractor performing 7 percent of contractor hours, with Next Phase self-performing the remainder. The derived hourly rate rose year-over-year.
Quick answers
Who was awarded contract 75F40122F80341?
75F40122F80341 was awarded to Next Phase Solutions And Services, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 30, 2022.
How much is contract 75F40122F80341 worth?
The government has obligated $4,499,216 on 75F40122F80341.
Is contract 75F40122F80341 an order under another contract?
Yes. 75F40122F80341 is a delivery order under 47QTCB21D0179, a government wide acquisition contract (GWAC), on 8(a) STARS III (STARS III).
Was contract 75F40122F80341 competed?
The extent of competition for 75F40122F80341 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award